positions available now

Tag Archives: New Zealand

Pharmac reverses controversial brand switch decision

Pharmac has been placed in the spotlight over their decision earlier in the year to fund only one brand of anti-epileptic medication, lamotrigine, instead of the previously funded three lamotrigine brands. Prior to the switch, Medsafe warned Pharmac that the … Continue reading

Posted in Market Access | Tagged , , , , | Comments Off on Pharmac reverses controversial brand switch decision

PHARMAC prepares to take over the procurement of medical devices

Access to medical devices in New Zealand is changing   The Therapeutic Products Bill will be published shortly, resulting in PHARMAC assuming responsibility for the procurement and funding of medical devices in addition to their current brief of medicines. This … Continue reading

Posted in Life Sciences Industry, Market Access, Medical Device | Tagged , , , , , , | Comments Off on PHARMAC prepares to take over the procurement of medical devices

NZ Regs Shake-up – what will become of medical devices?

The New Zealand Ministry of Health has announced that they are developing a new regime for the regulation of therapeutic products. Following the cessation of the Australia New Zealand Therapeutic Products Agency (ANZTPA), the New Zealand Ministry of Health is … Continue reading

Posted in Life Sciences Industry, Medical Device, Regulatory Services | Tagged , , , , | Comments Off on NZ Regs Shake-up – what will become of medical devices?
Copyright © 2014 Commercial Eyes